Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-160-9 | CAS number: 92-50-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted by the Council on July 21, 1997
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2-(N-ethylanilino)ethanol
- EC Number:
- 202-160-9
- EC Name:
- 2-(N-ethylanilino)ethanol
- Cas Number:
- 92-50-2
- Molecular formula:
- C10H15NO
- IUPAC Name:
- 2-(N-Ethylanilino)ethanol
- Test material form:
- liquid - solid: mixture of
- Details on test material:
- At room temperature, the substance can be either a primrose yellow solid or a liquid.
Constituent 1
- Specific details on test material used for the study:
- Batch/Lot Number 18052904
Analysed Concentration 99.47 %
(Refer Certificate of Analysis in APPENDIX 9)
Manufactured by Binhai Henglian Chemicals Co., Ltd.
Supplied to JRF by Aceto France SAS
Date of Manufacture May 29, 2018
Date of Expiry May 28, 2019
Other characteristics Water soluble in: 2000 mg/L
Appearance Primrose yellow solid/yellowish liquid
*At room temperature, the phase of the substance can be either solid or liquid
Storage Condition (at JRF):
- Storage Temperature : Kept at 0 – 30 0C, Away from light and humidity
- Storage Container :In original container as supplied by the Sponsor
- Storage Location : Test Item Control Office, JRF
Method
- Target gene:
- This test evaluates the test item for its ability to induce reverse mutations in the tester strains and restore the functional capability of the bacteria to synthesize an essential amino acid. In this case, the revertant bacteria are detected by their ability to grow in the absence of histidine, which is required by the Salmonella typhimurium tester strains.
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 fraction
- Test concentrations with justification for top dose:
- Initial Toxicity-Mutation Test: 5, 1.5, 0.5, 0.15, 0.05, 0.015, 0.005, 0.0015 µL/plate
Confirmatory Mutation Test: 0.16, 0.31, 0.63, 1.25, 2.5 and 5 µL/plate - Vehicle / solvent:
- dimethyl sulfoxide
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- mitomycin C
- other:
- Details on test system and experimental conditions:
- Source: The Salmonella typhimurium strains used in this study were mutants derived from Salmonella typhimurium LT2. The strains used in the study were obtained from Molecular Toxicology Inc., 157 Industrial Park Dr. Boone, NC 28607, U.S.A.
S9 fraction: buffered and supplemented with the essential co-factors β-NADP and Glucose-6-phosphate to form the “S9 mix”. This mix is added to the top agar in this activated assay. The S9 fractions procured from Dr. G.P. Meshram, Nagpur, and (Lot N° MWR/ARI/S9F/01/17 Sept 2017) was used in the study.
Cell Viability Test:
Fresh cultures for the test were prepared by inoculating frozen permanent cultures to a flask containing 10 mL of sterile nutrient broth N° 2 (Oxoid). The flasks were then incubated at 37 ± 1 °C in an orbital shaking incubator (120 rpm) for 15 h up to the early stationary or late exponential growth phase. After the incubation period, the culture flasks were removed from the orbital shaking incubator. The cultures were aseptically diluted with oxoid nutrient broth (ONB) and the optical density was measured at 660 nm using a spectrophotometer (Model Visiscan 167, Manufactured by Systronics). Oxoid nutrient broth was used as the control blank. Cell viability of the tester strains was determined prior to treatment. The optical density of the cultures was found to be in the acceptable range and so they were used for this study
Genotype Confirmation Test:
The genotype of the tester strain was confirmed for all the strains regularly (once in a month). The tester strains of Salmonella typhimurium were tested for histidine dependence, biotin dependence, histidine and biotin dependence, rfa mutation, uvrB mutation through sensitivity to ultraviolet light and the R-factor resistance for ampicillin and tetracycline.
Initial Toxicity-Mutation Test:
Tubes containing 2 mL of molten top agar with 0.5 mM histidine/biotin were maintained at 45 ± 2 °C. A volume of 500 µL of 0.2 M phosphate buffer was added in the absence of the metabolic activation system and 500 µL of 5% v/v S9 mix was added in the presence of the metabolic activation system. Volume of 100 µL of the relevant stock solution of test item, DMSO and relevant positive control were used for treatment, as a negative control and as a positive control, respectively. Finally, 100 µL of bacterial culture was added to the tubes and mixed. Cultures used were checked for cell viability prior to testing. Duplicate sets of plates were maintained for each concentration of test item, positive control and negative control. The petri plates were incubated at 37 ± 1 °C for 48 hours and then examined to assess the state of background bacterial lawn inhibition and reduction in the number of colonies.
Confirmatory Mutation Test:
Plates were maintained in triplicate for each test item concentration and for the positive control and negative control during both assays. The number of revertant colonies was recorded after the 48 h incubation period. Treatment with 2-aminoanthracene in the absence of metabolic activation was performed for tester strain TA100 in both the initial toxicity-mutation assay and confirmatory mutation assay to verify the efficiency of the S9 fraction used. - Rationale for test conditions:
- See details on test system and conditions.
- Evaluation criteria:
- A result is considered positive if a concentration-related increase over the range tested and/or a reproducible increase at one or more concentrations in the number of revertant colonies per plate in at least one strain with or without metabolic activation system.
Strains TA1535, TA1537:
Data sets were judged positive, if the increase in mean revertants at the peak of the dose response was equal to or greater than 3.0 times the mean negative control value.
Strain TA98, TA100 and TA102:
Data sets were judged positive, if the increase in mean revertants at the peak of the dose response was equal to or greater than 2.0 times the mean negative control value.
Statistical analysis was used as an aid in the evaluation of the dose response.
A response that did not meet all three of the above criteria (magnitude, concentration-responsiveness, reproducibility) was not judged as positive.
Negative results obtained in the initial toxicity-mutation test were confirmed by a second trial, using the same method as specified above, with an alteration in concentration spacing. - Statistics:
- Simple linear regression analysis was performed for TA1537, TA1535, TA98, TA100 and TA102, separately, to assess the dose dependent nature of any increase in revertant colonies.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Initial Toxicity-Mutation Test
Normal growth, in the background lawn, was observed, up to tested concentration of 5µL/plate in all tester strains, both in the absence and presence(5% v/v S9 mix)of the metabolic activation. Results revealed that there was no positive mutagenic effect in tester strains, up to the tested concentration of 5 µL/plate of2-(N-ethylanilino)ethanolin the absence and presence of the metabolic activation(5% v/v S9 mix), when compared with that of the negative control.Statistical analysis did not reveal any significant effect. Hence,0.16, 0.31, 0.63, 1.25, 2.5, and 5 µL/plate concentration levels of2-(N- ethylanilino)ethanolwere selected for the confirmatory mutation test in the absence and presence of the metabolic activation system(10% v/v s9 mix)for tester strains.
Confirmatory Mutation Test
Normal growth, in the background lawn, was observed, up to tested concentration of 5 µL/plate both in the absence and presence of the metabolic activation system (10% v/v S9 mix) in tester strains.Results revealed that there was no positive mutagenic effect in tester strains TA1537, TA1535, TA98, TA100, and TA102, at the tested concentration levels0.16, 0.31, 0.63, 1.25, 2.5 and 5 µL/plateof2-(N-ethylanilino)ethanol,intheabsence and presence of metabolic activation system (10% v/v S9 mix), when compared with the concurrent negative control. Statistical analysis did not reveal any significant effect.
A. Mean Count of His+Revertant Colonies in Negative Control, Positive Controls Treatment Plates in the Absence ofMetabolic Activation(Initial Toxicity-Mutation Test)
Concentration of 2-(N- Ethylanilino)Ethanol (µL/plate) |
His+Revertant Colonies/Plate (Absence of Metabolic Activation) |
|||||||||
TA1537 |
TA1535 |
TA98 |
TA100 |
TA102 |
||||||
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
|
NC (DMSO) |
8.50 |
0.71 |
17.00 |
1.41 |
24.00 |
5.66 |
133.50 |
6.36 |
226.00 |
5.66 |
0.0015 |
7.00 |
0.00 |
18.50 |
0.71 |
24.00 |
7.07 |
140.00 |
7.07 |
228.00 |
21.21 |
0.005 |
8.00 |
2.83 |
17.50 |
0.71 |
25.50 |
7.78 |
140.00 |
15.56 |
228.50 |
16.26 |
0.015 |
7.50 |
0.71 |
16.00 |
4.24 |
24.00 |
9.90 |
140.50 |
3.54 |
228.00 |
1.41 |
0.05 |
11.00 |
1.41 |
17.50 |
3.54 |
22.00 |
5.66 |
129.00 |
2.83 |
237.00 |
12.73 |
0.15 |
9.50 |
0.71 |
14.50 |
0.71 |
28.00 |
5.66 |
140.50 |
3.54 |
233.00 |
24.04 |
0.5 |
10.50 |
0.71 |
19.00 |
2.83 |
25.00 |
2.83 |
127.00 |
5.66 |
236.50 |
9.19 |
1.5 |
7.50 |
0.71 |
19.50 |
2.12 |
23.50 |
7.78 |
141.50 |
4.95 |
225.50 |
4.95 |
5 |
8.50 |
2.12 |
18.00 |
0.00 |
27.50 |
6.36 |
129.00 |
8.49 |
230.50 |
19.09 |
PC |
399.50 |
2.12 |
468.00 |
39.60 |
641.50 |
50.20 |
861.00 |
39.60 |
1062.00 |
14.14 |
2Aa |
- |
- |
- |
- |
- |
- |
143.50 |
7.78 |
- |
- |
Key: SD = Standard Deviation, NC = Negative Control, DMSO = Dimethyl sulfoxide, PC = Positive Control {TA1537 = 9-Aminoacridine Hydrochloride Monohydrate (75 µg/plate), TA1535 = Sodium Azide (0.5 µg/plate), TA98 = 2-Nitrofluorene (7.5 µg/plate), TA100 = Sodium Azide (5 µg/plate), TA102 = Mitomycin-C (0.5µg/plate)}, 2-Aa = 2-Aminoanthracene (5 µg/plate for TA100),- = Not Applicable.
B. Mean Count of His+Revertant Colonies in Negative Control, Positive Control and Treatment Plates in the Presence ofMetabolic Activation(Initial Toxicity-Mutation Test)
Concentration of 2-(N- Ethylanilino)Ethanol (µL/plate) |
His+Revertant Colonies/Plate [Presence of Metabolic Activation (5% v/v S9 mix)] |
|||||||||
TA1537 |
TA1535 |
TA98 |
TA100 |
TA102 |
||||||
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
|
NC (DMSO) |
7.50 |
0.71 |
21.50 |
4.95 |
26.50 |
7.78 |
140.50 |
4.95 |
248.00 |
11.31 |
0.0015 |
6.50 |
2.12 |
23.00 |
1.41 |
29.00 |
8.49 |
131.50 |
6.36 |
240.00 |
9.90 |
0.005 |
6.50 |
0.71 |
19.50 |
2.12 |
26.50 |
6.36 |
129.50 |
9.19 |
256.00 |
2.83 |
0.015 |
7.50 |
2.12 |
20.00 |
1.41 |
28.00 |
5.66 |
129.50 |
6.36 |
237.00 |
5.66 |
0.05 |
7.00 |
1.41 |
20.50 |
6.36 |
27.00 |
5.66 |
129.00 |
11.31 |
250.50 |
4.95 |
0.15 |
6.50 |
0.71 |
20.00 |
4.24 |
27.00 |
7.07 |
130.00 |
8.49 |
231.50 |
4.95 |
0.5 |
9.00 |
1.41 |
22.50 |
7.78 |
25.00 |
9.90 |
132.50 |
21.92 |
247.00 |
15.56 |
1.5 |
10.00 |
0.00 |
17.50 |
2.12 |
27.00 |
5.66 |
131.50 |
10.61 |
248.50 |
10.61 |
5 |
7.50 |
0.71 |
20.00 |
1.41 |
28.50 |
9.19 |
135.00 |
18.38 |
242.00 |
25.46 |
PC-2Aa |
264.00 |
0.00 |
552.00 |
46.67 |
755.00 |
25.46 |
945.00 |
24.04 |
1160.50 |
33.23 |
Key: SD = Standard Deviation, NC = Negative Control, DMSO = Dimethyl sulfoxide, PC = Positive control, 2Aa = 2-Aminoanthracene (10 µg/plate for TA1537, TA1535, TA102 and 5 µg/plate for TA98 and TA100
C. Mean Count of His+Revertant Colonies in Negative Control, Positive Controls and Treatment Plates in the Absence of Metabolic Activation (Confirmatory Mutation Test)
Concentration of 2-(N- Ethylanilino)Ethanol (µL/plate) |
His+Revertant Colonies/Plate [Absence of Metabolic Activation] |
|||||||||
TA1537 |
TA1535 |
TA98 |
TA100 |
TA102 |
||||||
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
|
NC (DMSO) |
10.33 |
3.21 |
19.00 |
3.61 |
27.33 |
2.31 |
135.33 |
19.09 |
226.67 |
23.71 |
0.16 |
9.67 |
1.53 |
18.33 |
2.08 |
26.00 |
2.00 |
143.67 |
10.21 |
233.67 |
34.20 |
0.31 |
9.33 |
3.06 |
18.67 |
2.08 |
27.33 |
4.73 |
116.67 |
15.31 |
234.67 |
12.42 |
0.63 |
10.67 |
1.53 |
20.00 |
4.00 |
29.33 |
2.08 |
135.00 |
14.93 |
224.00 |
15.10 |
1.25 |
9.00 |
1.00 |
20.33 |
2.52 |
28.33 |
1.53 |
129.67 |
23.01 |
229.00 |
7.94 |
2.5 |
12.00 |
2.65 |
20.33 |
1.15 |
26.00 |
3.00 |
120.00 |
12.12 |
229.67 |
11.59 |
5 |
8.67 |
0.58 |
19.33 |
3.79 |
29.33 |
2.31 |
125.33 |
7.02 |
226.67 |
17.39 |
PC |
296.33 |
39.68 |
419.00 |
65.37 |
561.67 |
54.85 |
821.33 |
70.27 |
1054.33 |
28.54 |
2Aa |
- |
- |
- |
- |
- |
- |
122.67 |
5.51 |
- |
- |
Key: SD = Standard Deviation, NC = Negative Control, DMSO = Dimethyl sulfoxide,PC = Positive Control {TA1537 = 9-Aminoacridine Hydrochloride Monohydrate (75 µg/plate), TA1535 = Sodium Azide (0.5 µg/plate), TA98 = 2-Nitrofluorene (7.5 µg/plate), TA100 = Sodium Azide (5 µg/plate), TA102 = Mitomycin-C (0.5 µg/plate)}, 2-Aa = 2-Aminoanthracene (5 µg/plate for TA100),- = Not Applicable
D. Mean Count of His+Revertant Colonies in Negative Control, Positive Control and Treatment Plates in the Presence ofMetabolic Activation(Confirmatory Mutation Test)
Concentration of 2-(N- Ethylanilino)Ethanol (µL/plate) |
His+Revertant Colonies/Plate [Presence of Metabolic Activation (10% v/v S9 mix)] |
|||||||||
TA1537 |
TA1535 |
TA98 |
TA100 |
TA102 |
||||||
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
Mean |
SD |
|
NC (DMSO) |
11.67 |
2.52 |
18.67 |
2.52 |
27.00 |
1.00 |
135.33 |
0.58 |
227.67 |
13.65 |
0.16 |
10.00 |
2.65 |
18.67 |
2.89 |
27.67 |
1.53 |
128.00 |
23.52 |
217.33 |
14.01 |
0.31 |
10.67 |
3.79 |
19.00 |
3.00 |
27.67 |
1.53 |
132.33 |
14.57 |
236.67 |
11.02 |
0.63 |
11.33 |
2.08 |
16.00 |
2.00 |
25.67 |
2.52 |
129.67 |
4.62 |
227.67 |
17.95 |
1.25 |
11.33 |
1.53 |
21.33 |
2.08 |
29.00 |
5.57 |
130.33 |
11.59 |
227.00 |
3.61 |
2.5 |
10.33 |
2.08 |
20.33 |
5.51 |
28.67 |
3.21 |
130.67 |
12.42 |
225.33 |
14.01 |
5 |
9.00 |
1.00 |
17.67 |
1.53 |
29.00 |
2.65 |
131.33 |
11.68 |
220.00 |
16.09 |
PC-2Aa |
329.33 |
48.95 |
506.67 |
70.73 |
665.67 |
40.70 |
898.67 |
57.49 |
1053.00 |
99.98 |
Key: SD = Standard Deviation, NC = Negative Control,DMSO = Dimethyl sulfoxide,PC = Positive Control, 2Aa = 2-Aminoanthracene(10 µg/plate for TA1537, TA1535, TA102 and 5 µg/plate for TA98 and TA100.
.
Applicant's summary and conclusion
- Conclusions:
- From results of this study, it is concluded that 2-(N-ethylanilino)ethanol is non-mutagenic to any of the five strains of Salmonella typhimurium viz., TA1537, TA1535, TA98, TA100, and TA102 when tested under the specified experimental conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)